Martin Shkreli, the former drug company executive who made headlines by jacking up the price of a lifesaving drug before he was found guilty of defrauding investors, is scheduled to be sentenced on Friday.
Shkreli, 34, is expected to appear before U.S. District Judge Kiyo Matsumoto in federal court in Brooklyn, New York. His lawyers have asked the judge to impose a sentence of 12 to 18 months, while prosecutors have sought at least 15 years.
The Brooklyn-born entrepreneur first became famous as the "Pharma Bro" in September 2015 after founding Turing Pharmaceuticals, buying the anti-parasitic drug Daraprim and raising its price by 5,000 percent, to $750 per pill. Shkreli was indicted for the unrelated securities fraud charges months later, in December 2015.